» Articles » PMID: 38528281

Real-life Management of Patients with Mild Cognitive Impairment: an Italian Survey

Overview
Journal Neurol Sci
Specialty Neurology
Date 2024 Mar 26
PMID 38528281
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Mild cognitive impairment (MCI) is a syndrome with heterogeneous underlying causes and different rates of disease progression, whose clinical heterogeneity leads to a wide variation in diagnostic and therapeutic approaches in clinical practice. The lack of uniform practical recommendations on diagnostic workup and treatment for MCI patients hinders optimal management of these patients, worsening their prognosis. Standardized guidelines for the investigation and follow-up of MCI are therefore urgently required.

Aim: Aim of our study was to assess the diagnostic and therapeutic approach to MCI patients in the setting of Italian Memory Clinics.

Methods: A survey was delivered to a sample of Italian neurologists through two different phases: a first exploratory phase recording general information about the usual clinical management of patients with MCI, and a subsequent operative phase assessing the practical diagnostic and therapeutic decisions taken in a real life setting to manage subjects with MCI.

Results: A total of 121 neurologists participated to the first phase of the survey and 203 patients were enrolled in the second phase. Information gathered in the first phase of the survey highlighted a non-uniform use of diagnostic criteria and procedures for MCI, as well as a very heterogeneous therapeutic strategy among Italian neurologists. In the second phase, recorded data on diagnostic and therapeutic approach confirmed the large variability observed in the first phase of the survey.

Conclusions: The results of our study reflect a suboptimal management of MCI patients in Italy and highlight the need of standardized diagnostic and therapeutic approaches for this condition.

References
1.
Lane C, Barnes J, Nicholas J, Sudre C, Cash D, Malone I . Associations Between Vascular Risk Across Adulthood and Brain Pathology in Late Life: Evidence From a British Birth Cohort. JAMA Neurol. 2019; 77(2):175-183. PMC: 6830432. DOI: 10.1001/jamaneurol.2019.3774. View

2.
Jack Jr C, Bennett D, Blennow K, Carrillo M, Dunn B, Budd Haeberlein S . NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018; 14(4):535-562. PMC: 5958625. DOI: 10.1016/j.jalz.2018.02.018. View

3.
Sachdev P, Lipnicki D, Kochan N, Crawford J, Thalamuthu A, Andrews G . The Prevalence of Mild Cognitive Impairment in Diverse Geographical and Ethnocultural Regions: The COSMIC Collaboration. PLoS One. 2015; 10(11):e0142388. PMC: 4634954. DOI: 10.1371/journal.pone.0142388. View

4.
Putignano S, Gareri P, Castagna A, Cerqua G, Cervera P, Cotroneo A . Retrospective and observational study to assess the efficacy of citicoline in elderly patients suffering from stupor related to complex geriatric syndrome. Clin Interv Aging. 2012; 7:113-8. PMC: 3363302. DOI: 10.2147/CIA.S29366. View

5.
Cotroneo A, Castagna A, Putignano S, Lacava R, Fanto F, Monteleone F . Effectiveness and safety of citicoline in mild vascular cognitive impairment: the IDEALE study. Clin Interv Aging. 2013; 8:131-7. PMC: 3569046. DOI: 10.2147/CIA.S38420. View